Takeda San Diego, 10410 Science Center Drive, San Diego, CA 92121, United States
Abstract:
A novel series of pyrrole inhibitors of MEK kinase has been developed using structure-based drug design. Optimization of the series led to the identification of potent inhibitors with good pharmaceutical properties.